Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Jiang, Jing ^a   Jia, Zhi Fang ^a   Kong, Fei ^a   Jin, Mei Shan ^a   Wang, Yin Ping ^a   Tian, Suyan ^a   Suo, Jian ^a   Cao, Xueyuan ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I; PEPSINOGEN II; PROTEIN SH2;

ADULT; AGED; ALLELE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROSCOPY; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CODE; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PTPN11 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ATROPHY; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTRITIS, ATROPHIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; STOMACH NEOPLASMS;

EID: 84863661971     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-89     Document Type: Article

References (34)

1. WHO classification of tumors 2000, Lyon: IARC Press, Hamiliton SR, Aaltonen L.
2. Dai M, Ren JS, Li N, Li Q, Yang L, Chen YH. Estimation and prediction on cancer related incidence and mortality in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi 2012, 33(1):57-61.
3. Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 2007, 21(2):281-297. 10.1016/j.bpg.2007.02.002, 17382277.
4. Kabir S. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter 2009, 14(3):159-171. 10.1111/j.1523-5378.2009.00677.x, 19702845.
5. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008, 134(1):306-323. 10.1053/j.gastro.2007.11.009, 18166359.
6. Snaith A, El-Omar EM. Helicobacter pylori: host genetics and disease outcomes. Expert Rev Gastroenterol Hepatol 2008, 2(4):577-585. 10.1586/17474124.2.4.577, 19072405.
7. Hishida A, Matsuo K, Goto Y, Hamajima N. Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol 2010, 2(10):369-379. 10.4251/wjgo.v2.i10.369, 2999673, 21160888.
8. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995, 87(23):1777-1780. 10.1093/jnci/87.23.1777, 7473834.
9. Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M, Azuma T. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 2003, 187(2):334-337. 10.1086/367807, 12552462.
10. Hatakeyama M. The role of Helicobacter pylori CagA in gastric carcinogenesis. Int J Hematol 2006, 84(4):301-308. 10.1532/IJH97.06166, 17118755.
11. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol 2009, 44(4):239-248. 10.1007/s00535-009-0014-1, 19271114.
12. Hatakeyama M. Relationship between Helicobacter pylori CagA-SHP-2 interaction and gastric cancer. Nihon Rinsho 2005, 63(Suppl 11):48-52.
13. Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 2008, 27(2):179-192. 10.1007/s10555-008-9126-y, 18286234.
14. Grossmann KS, Rosario M, Birchmeier C, Birchmeier W. The tyrosine phosphatase Shp2 in development and cancer. Adv Cancer Res 2010, 106:53-89.
15. Jongmans MC, van der Burgt I, Hoogerbrugge PM, Noordam K, Yntema HG, Nillesen WM, Kuiper RP, Ligtenberg MJ, van Kessel AG, van Krieken JH, et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet 2011, 19(8):870-874. 10.1038/ejhg.2011.37, 3172922, 21407260.
16. Kim JS, Shin OR, Kim HK, Cho YS, An CH, Lim KW, Kim SS. Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas. Dig Dis Sci 2010, 55(6):1565-1569. 10.1007/s10620-009-0924-z, 19690960.
17. Jamshidi Y, Gooljar SB, Snieder H, Wang X, Ge D, Swaminathan R, Spector TD, O'Dell SD. SHP-2 and PI3-kinase genes PTPN11 and PIK3R1 may influence serum apoB and LDL cholesterol levels in normal women. Atherosclerosis 2007, 194(2):e26-e33. 10.1016/j.atherosclerosis.2006.12.013, 2084489, 17214991.
18. Lu Y, Dolle ME, Imholz S, van 't Slot R, Verschuren WM, Wijmenga C, Feskens EJ, Boer JM. Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. J Lipid Res 2008, 49(12):2582-2589. 10.1194/jlr.M800232-JLR200, 18660489.
19. Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, Goto H, Hamajima N. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 2006, 118(1):203-208. 10.1002/ijc.21338, 16032704.
20. Hamajima N, Rahimov B, Malikov Y, Abdiev S, Ahn KS, Bahramov S, Kawai S, Nishio K, Naito M, Goto Y. Associations between a PTPN11 polymorphism and gastric atrophy-opposite in Uzbekistan to that in Japan. Asian Pac J Cancer Prev 2008, 9(2):217-220.
21. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol 2009, 9:51. 10.1186/1471-230X-9-51, 2715419, 19589142.
22. Kawai S, Goto Y, Ito LS, Oba-Shinjo SM, Uno M, Shinjo SK, Marie SK, Ishida Y, Nishio K, Naito M, et al. Significant association between PTPN11 polymorphism and gastric atrophy among Japanese Brazilians. Gastric Cancer 2006, 9(4):277-283. 10.1007/s10120-006-0391-6, 17235629.
23. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007, 8(1):15-22. 10.1111/j.1443-9573.2007.00271.x, 17261130.
24. De La Vega FM. Selecting single-nucleotide polymorphisms for association studies with SNPbrowser software. Methods Mol Biol 2007, 376:177-193. 10.1007/978-1-59745-389-9_13, 17984546.
25. Lin DY, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 2005, 29(4):299-312. 10.1002/gepi.20098, 16240443.
26. Zeng D, Lin DY, Avery CL, North KE, Bray MS. Efficient semiparametric estimation of haplotype-disease associations in case-cohort and nested case-control studies. Biostatistics 2006, 7(3):486-502.
27. Zhu F, Loh M, Hill J, Lee S, Koh KX, Lai KW, Salto-Tellez M, Iacopetta B, Yeoh KG, Soong R. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. BMC Gastroenterol 2009, 9:76. 10.1186/1471-230X-9-76, 2766386, 19822020.
28. Zhang LWP, Liang H, Wen J, Jiang J, Zhang Z, Wei S, Liu C. Correlation of PTPN11 polymorphism at intron 3 with gastric cancer. Med J chin PLA 2011, 36(5):474-477.
29. Zheng H, Alter S, Qu CK. SHP-2 tyrosine phosphatase in human diseases. Int J Clin Exp Med 2009, 2(1):17-25. 2680053, 19436828.
30. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002, 295(5555):683-686. 10.1126/science.1067147, 11743164.
31. Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 2007, 22(11):1251-1267. 2515712, 17647198.
32. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997, 35(7):1710-1714. 229827, 9196179.
33. Miehlke S, Kibler K, Kim JG, Figura N, Small SM, Graham DY, Go MF. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 1996, 91(7):1322-1325.
34. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, van der Ende A. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 1997, 35(6):1344-1347. 229746, 9163441.